139 related articles for article (PubMed ID: 22546668)
21. 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions.
Sun W; Liu K; Ryu H; Kang DW; Kim YS; Kim MS; Cho Y; Bhondwe RS; Thorat SA; Kim HS; Pearce LV; Pavlyukovets VA; Tran R; Morgan MA; Lazar J; Ryder CB; Toth A; Blumberg PM; Lee J
Bioorg Med Chem; 2012 Feb; 20(3):1310-8. PubMed ID: 22227463
[TBL] [Abstract][Full Text] [Related]
22. The SAR analysis of TRPV1 agonists with the α-methylated B-region.
Cho Y; Kim MS; Kim HS; Ann J; Lee J; Pearce LV; Pavlyukovets VA; Morgan MA; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2012 Aug; 22(16):5227-31. PubMed ID: 22796184
[TBL] [Abstract][Full Text] [Related]
23. N-(3-Acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics.
Lee J; Lee J; Kim J; Kim SY; Chun MW; Cho H; Hwang SW; Oh U; Park YH; Marquez VE; Beheshti M; Szabo T; Blumberg PM
Bioorg Med Chem; 2001 Jan; 9(1):19-32. PubMed ID: 11197340
[TBL] [Abstract][Full Text] [Related]
24. High affinity antagonists of the vanilloid receptor.
Wang Y; Szabo T; Welter JD; Toth A; Tran R; Lee J; Kang SU; Suh YG; Blumberg PM; Lee J
Mol Pharmacol; 2002 Oct; 62(4):947-56. PubMed ID: 12237342
[TBL] [Abstract][Full Text] [Related]
25. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
[TBL] [Abstract][Full Text] [Related]
26. The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.
Lim KS; Lee H; Kim SE; Ha TH; Ann J; Son K; Choi S; Sun W; Pearce LV; DeAndrea-Lazarus IA; Blumberg PM; Lee J
Eur J Med Chem; 2013 Oct; 68():233-43. PubMed ID: 23981530
[TBL] [Abstract][Full Text] [Related]
27. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
[TBL] [Abstract][Full Text] [Related]
28. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.
Kim MS; Ryu H; Kang DW; Cho SH; Seo S; Park YS; Kim MY; Kwak EJ; Kim YS; Bhondwe RS; Kim HS; Park SG; Son K; Choi S; DeAndrea-Lazarus IA; Pearce LV; Blumberg PM; Frank R; Bahrenberg G; Stockhausen H; Kögel BY; Schiene K; Christoph T; Lee J
J Med Chem; 2012 Oct; 55(19):8392-408. PubMed ID: 22957803
[TBL] [Abstract][Full Text] [Related]
29. The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation.
Papakosta M; Dalle C; Haythornthwaite A; Cao L; Stevens EB; Burgess G; Russell R; Cox PJ; Phillips SC; Grimm C
J Biol Chem; 2011 Nov; 286(45):39663-72. PubMed ID: 21911503
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of oxazolo[4,5-c]quinoline TRPV1 antagonists.
Voight EA; Daanen JF; Kort ME
J Org Chem; 2010 Dec; 75(24):8713-5. PubMed ID: 21090730
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim MS; Ki Y; Ahn SY; Yoon S; Kim SE; Park HG; Sun W; Son K; Cui M; Choi S; Pearce LV; Esch TE; Deandrea-Lazarus IA; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2014 Jan; 24(1):382-5. PubMed ID: 24321344
[TBL] [Abstract][Full Text] [Related]
32. Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Ann J; Jung A; Kim MY; Kim HM; Ryu H; Kim S; Kang DW; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2015 Nov; 23(21):6844-54. PubMed ID: 26474664
[TBL] [Abstract][Full Text] [Related]
33. High-affinity partial agonists of the vanilloid receptor.
Wang Y; Toth A; Tran R; Szabo T; Welter JD; Blumberg PM; Lee J; Kang SU; Lim JO; Lee J
Mol Pharmacol; 2003 Aug; 64(2):325-33. PubMed ID: 12869637
[TBL] [Abstract][Full Text] [Related]
34. N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands.
Lee J; Lee J; Szabo T; Gonzalez AF; Welter JD; Blumberg PM
Bioorg Med Chem; 2001 Jul; 9(7):1713-20. PubMed ID: 11425572
[TBL] [Abstract][Full Text] [Related]
35. Conformationally constrained analogues of N'-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists.
Lim JO; Jin MK; Ryu H; Kang DW; Lee J; Pearce LV; Tran R; Toth A; Blumberg PM
Eur J Med Chem; 2009 Jan; 44(1):322-31. PubMed ID: 18406014
[TBL] [Abstract][Full Text] [Related]
36. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists.
Gore VK; Ma VV; Tamir R; Gavva NR; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2007 Nov; 17(21):5825-30. PubMed ID: 17851073
[TBL] [Abstract][Full Text] [Related]
38. Promiscuous gating modifiers target the voltage sensor of K(v)7.2, TRPV1, and H(v)1 cation channels.
Kornilov P; Peretz A; Lee Y; Son K; Lee JH; Refaeli B; Roz N; Rehavi M; Choi S; Attali B
FASEB J; 2014 Jun; 28(6):2591-602. PubMed ID: 24599966
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
[TBL] [Abstract][Full Text] [Related]
40. 2-Methylacrylamide as a bioisoster of thiourea group for 1,3-dibenzylthioureido TRPV1 receptor antagonists.
Park SR; Kim J; Lee SY; Park YH; Kim HD
Bioorg Med Chem Lett; 2018 Jun; 28(11):2080-2083. PubMed ID: 29709253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
